Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
138.48
-0.39 (-0.28%)
At close: Dec 26, 2025
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $267.64 billion as of December 26, 2025. Its market cap has increased by 30.23% in one year.
Market Cap
267.64B
Enterprise Value
290.64B
Revenue
56.37B
Ranking
n/a
PE Ratio
18.59
Stock Price
$138.48
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 267.64B, an increase of 110.16%. That is a compound annual growth rate of 2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 267.64B | 36.89% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |